Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?

Edgewise Therapeutics Ownership Summary

Edgewise Therapeutics is owned by 32.91% institutional investors, 0.45% insiders, and 66.64% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.79% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Edgewise Therapeutics shares.

EWTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edgewise Therapeutics	32.91%	0.45%	66.64%
Sector	Healthcare Stocks	232.20%	10.74%	-142.94%
Industry	Biotech Stocks	382.11%	10.55%	-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	15.52M	14.79%	$251.71M
Ra capital management	10.43M	9.94%	$169.15M
Baker bros. advisors lp	7.31M	6.96%	$118.50M
Blackrock	6.02M	6.87%	$108.34M
Blackrock funding, inc. /de	6.63M	6.29%	$164.54M
Paradigm biocapital advisors lp	6.17M	5.88%	$100.08M
Janus henderson group	4.98M	5.31%	$133.04M
Novo	5.35M	5.10%	$86.78M
Braidwell lp	5.21M	4.97%	$84.52M
Vanguard group	4.87M	4.62%	$120.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.03M	38.82%	$16.71M
Orbimed advisors	15.52M	5.93%	$251.71M
Novo	5.35M	5.59%	$86.78M
Bioimpact capital	1.72M	4.57%	$27.91M
Cormorant asset management, lp	4.01M	4.49%	$65.04M
Paradigm biocapital advisors lp	6.17M	2.85%	$100.08M
Braidwell lp	5.21M	2.51%	$84.52M
Siren	3.90M	2.47%	$63.21M
First light asset management	1.41M	2.16%	$22.95M
Ra capital management	10.43M	2.08%	$169.15M

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	2.91M	0.00%	2.04M
Ubs group	2.12M	0.01%	2.00M
Soleus capital management	910.00K	0.83%	910.00K
Blackrock	6.02M	0.00%	848.71K
Norges bank	751.36K	0.00%	751.36K

Top Sellers

Holder	Shares	% Assets	Change
Tcg crossover management	-	-	-2.11M
Deep track capital, lp	-	-	-1.40M
Deerfield management company, l.p. (series c)	765.69K	0.19%	-1.30M
Frazier life sciences management	-	-	-1.27M
Ecor1 capital	-	-	-1.25M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	751.36K	0.00%	751.36K	$18.64M
Silverarc capital management	42.05K	0.14%	42.05K	$1.04M
Knights of columbus asset advisors	38.68K	0.05%	38.68K	$959.75K
Trexquant investment lp	22.63K	0.00%	22.63K	$366.98K
State of new jersey common pension fund d	17.98K	0.00%	17.98K	$446.12K

Sold Out

Holder	Change
American national bank	-2.00
Clearstead advisors	-4.00
Creekmur asset management	-8.00
Nelson, van denburg & campbell wealth management group	-8.00
Newedge advisors	-9.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	109	-39.11%	34,717,234	-68.99%	32	0.29%	62	-23.46%	26	-57.38%
Sep 30, 2025	176	1.15%	111,963,848	-3.66%	106	0.87%	78	-31.58%	61	60.53%
Jun 30, 2025	182	-15.35%	118,716,112	13.87%	113	0.94%	118	13.46%	39	-40.00%
Mar 31, 2025	214	1.42%	105,276,596	6.36%	110	0.99%	104	-14.05%	63	5.00%
Dec 31, 2024	67	-64.55%	17,838,374	-82.39%	19	0.16%	35	-68.75%	20	-53.49%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.82M	2.68%	-62.61K
Vanguard US Total Market Shares ETF	2.54M	2.67%	-5.23K
iShares Russell 2000 ETF	1.76M	1.67%	-
BB Biotech AG Ord	1.43M	1.51%	-
Fidelity Small Cap Growth	983.35K	1.05%	-284.60K
Polar Capital Biotech S Inc	975.00K	0.93%	-
Artisan International Small-Mid Investor	914.19K	0.87%	281.23K
Artisan Non-U.S. Small-Mid Growth Comp	914.19K	0.87%	281.23K
Janus Henderson Global Life Sciences	838.14K	0.80%	153.58K
Janus Henderson Global Life Sciences D	838.14K	0.80%	-8.23K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 21, 2026	Edris Badreddin	-	Sell	$308.03K
Jan 21, 2026	Edris Badreddin	-	Sell	$223.89K
Jan 21, 2026	Edris Badreddin	-	Sell	$507.43K
Jan 21, 2026	Edris Badreddin	-	Sell	$403.03K
Jan 21, 2026	Edris Badreddin	-	Sell	$1.96M

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	5
2025 Q4	1	1
2025 Q3	-	7
2025 Q2	4	6
2025 Q1	-	8

EWTX Ownership FAQ

Who Owns Edgewise Therapeutics?

Edgewise Therapeutics shareholders are primarily institutional investors at 32.91%, followed by 0.45% insiders and 66.64% retail investors. The average institutional ownership in Edgewise Therapeutics's industry, Biotech Stocks , is 382.11%, which Edgewise Therapeutics falls below.

Who owns the most shares of Edgewise Therapeutics?

Edgewise Therapeutics’s largest shareholders are Orbimed advisors (15.52M shares, 14.79%), Ra capital management (10.43M shares, 9.94%), and Baker bros. advisors lp (7.31M shares, 6.96%). Together, they hold 31.69% of Edgewise Therapeutics’s total shares outstanding.

Does Blackrock own Edgewise Therapeutics?

Yes, BlackRock owns 6.87% of Edgewise Therapeutics, totaling 6.02M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 108.34M$. In the last quarter, BlackRock increased its holdings by 848.7K shares, a 16.43% change.

Who is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested, with 38.82% of its assets in 1.03M Edgewise Therapeutics shares, valued at 16.71M$.

Who is the top mutual fund holder of Edgewise Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Edgewise Therapeutics shares, with 2.68% of its total shares outstanding invested in 2.82M Edgewise Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools